109 related articles for article (PubMed ID: 8148801)
21. Two different conformations of the antitumor beta-D-glucan produced by Sclerotinia sclerotiorum IFO 9395.
Ohno N; Yadomae T
Carbohydr Res; 1987 Feb; 159(2):293-302. PubMed ID: 3567988
[TBL] [Abstract][Full Text] [Related]
22. Effect of orally administered beta-glucan on macrophage function in mice.
Suzuki I; Tanaka H; Kinoshita A; Oikawa S; Osawa M; Yadomae T
Int J Immunopharmacol; 1990; 12(6):675-84. PubMed ID: 2272730
[TBL] [Abstract][Full Text] [Related]
23. Oral administration of SSG, a beta-glucan obtained from Sclerotinia sclerotiorum, affects the function of Peyer's patch cells.
Hashimoto K; Suzuki I; Yadomae T
Int J Immunopharmacol; 1991; 13(4):437-42. PubMed ID: 1828793
[TBL] [Abstract][Full Text] [Related]
24. Changes in immune mediators in mouse lung produced by administration of soluble (1-->3)-beta-D-glucan.
Sakurai T; Ohno N; Yadomae T
Biol Pharm Bull; 1994 May; 17(5):617-22. PubMed ID: 7920419
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of experimental pulmonary metastasis of Lewis lung carcinoma by orally administered beta-glucan in mice.
Suzuki I; Sakurai T; Hashimoto K; Oikawa S; Masuda A; Ohsawa M; Yadomae T
Chem Pharm Bull (Tokyo); 1991 Jun; 39(6):1606-8. PubMed ID: 1934182
[TBL] [Abstract][Full Text] [Related]
26. Orally administered beta-glucans enhance anti-tumor effects of monoclonal antibodies.
Cheung NK; Modak S; Vickers A; Knuckles B
Cancer Immunol Immunother; 2002 Nov; 51(10):557-64. PubMed ID: 12384807
[TBL] [Abstract][Full Text] [Related]
27. Protective effect of beta-glucan against systemic Streptococcus pneumoniae infection in mice.
Hetland G; Ohno N; Aaberge IS; Lovik M
FEMS Immunol Med Microbiol; 2000 Feb; 27(2):111-6. PubMed ID: 10640605
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of LPS triggered TNF-alpha (tumor necrosis factor-alpha) production by (1-->3)-beta-D-glucans in mice.
Ohno N; Asada N; Adachi Y; Yadomae T
Biol Pharm Bull; 1995 Jan; 18(1):126-33. PubMed ID: 7735226
[TBL] [Abstract][Full Text] [Related]
29. Immunopharmacological characterization of a highly branched fungal (1-->3)-beta-D-glucan, OL-2, isolated from Omphalia lapidescens.
Ohno N; Saito K; Nemoto J; Kaneko S; Adachi Y; Nishijima M; Miyazaki T; Yadomae T
Biol Pharm Bull; 1993 Apr; 16(4):414-9. PubMed ID: 8358393
[TBL] [Abstract][Full Text] [Related]
30. Effect of beta-glucans on the nitric oxide synthesis by peritoneal macrophage in mice.
Ohno N; Egawa Y; Hashimoto T; Adachi Y; Yadomae T
Biol Pharm Bull; 1996 Apr; 19(4):608-12. PubMed ID: 8860968
[TBL] [Abstract][Full Text] [Related]
31. Enhancing effect of new biological response modifier sulfoethylated (1-->3)-beta-D-glucan on antitumor activity of cyclophosphamide in the treatment of experimental murine leukoses.
Khalikova TA; Korolenko TA; Zhanaeva SY; Kaledin VI; Kogan G
Exp Oncol; 2006 Dec; 28(4):308-13. PubMed ID: 17285116
[TBL] [Abstract][Full Text] [Related]
32. A water-soluble aminated beta 1-3D-glucan derivative causes regression of solid tumors in mice.
Seljelid R
Biosci Rep; 1986 Sep; 6(9):845-51. PubMed ID: 3814772
[TBL] [Abstract][Full Text] [Related]
33. Antitumor activity of carboxymethylglucans obtained by carboxymethylation of (1 leads to 3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes IFO 13140.
Sasaki T; Abiko N; Nitta K; Takasuka N; Sugino Y
Eur J Cancer (1965); 1979 Feb; 15(2):211-5. PubMed ID: 436898
[No Abstract] [Full Text] [Related]
34. Th1/Th2-Balancing immunomodulating activity of gel-forming (1-->3)-beta-glucans from fungi.
Suzuki Y; Adachi Y; Ohno N; Yadomae T
Biol Pharm Bull; 2001 Jul; 24(7):811-9. PubMed ID: 11456123
[TBL] [Abstract][Full Text] [Related]
35. Oral (1-->3),(1-->4)-beta-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastoma.
Cheung NK; Modak S
Clin Cancer Res; 2002 May; 8(5):1217-23. PubMed ID: 12006541
[TBL] [Abstract][Full Text] [Related]
36. Preparation and antigen specificity of an anti-(1-->3)-beta-D-glucan antibody.
Adachi Y; Ohno N; Yadomae T
Biol Pharm Bull; 1994 Nov; 17(11):1508-12. PubMed ID: 7703974
[TBL] [Abstract][Full Text] [Related]
37. Structure-activity relationship of (1-->3)-beta-D-glucans in the induction of cytokine production from macrophages, in vitro.
Okazaki M; Adachi Y; Ohno N; Yadomae T
Biol Pharm Bull; 1995 Oct; 18(10):1320-7. PubMed ID: 8593430
[TBL] [Abstract][Full Text] [Related]
38. Antitumor effect of a peptide-glucan preparation extracted from Agaricus blazei in a double-grafted tumor system in mice.
Ebina T; Fujimiya Y
Biotherapy; 1998; 11(4):259-65. PubMed ID: 9950102
[TBL] [Abstract][Full Text] [Related]
39. Antitumor and antimetastatic activity of a novel water-soluble low molecular weight beta-1, 3-D-glucan (branch beta-1,6) isolated from Aureobasidium pullulans 1A1 strain black yeast.
Kimura Y; Sumiyoshi M; Suzuki T; Sakanaka M
Anticancer Res; 2006; 26(6B):4131-41. PubMed ID: 17201124
[TBL] [Abstract][Full Text] [Related]
40. Antitumor activity and structural characterization of a (1----3)-beta-D-glucan extracted with cold alkali from sclerotia of Sclerotinia sclerotiorum IFO 9395.
Shinohara H; Ohno N; Yadomae T
Chem Pharm Bull (Tokyo); 1988 Feb; 36(2):819-23. PubMed ID: 3409388
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
